Npac Regulates Pre-mRNA Splicing in Mouse Embryonic Stem Cells
Abstract
:1. Introduction
2. Results
2.1. Loss of Npac Disrupts Pluripotency and Identity in mESCs
2.2. Transcriptomic Changes Induced by Npac Knockout
2.3. Potential Effects of Npac Knockout on Cellular Proliferation and Apoptosis
2.4. Knockout of Npac Results in Transcriptional Elongation Defect
2.5. Npac Regulates Alternative Splicing Events in mESCs
2.6. Npac Interacts with Splicing Factors
2.7. Npac Interacts with Components of Spliceosomal Machinery
3. Discussion
4. Materials and Methods
4.1. Antibodies
4.2. Cell Culture
4.2.1. Generation of CRISPR/Cas9 Knockout ESCs
Plasmid | Primer |
exon3-sgRNA-F1 | atgCGTCTCaACCGAGCGTTCATAACTCTACATGgttttagagctagaaatagcaag |
exon3-sgRNA-R1 | atgCGTCTCgAAACCGAGTCATTGCAATAAGACTCGGTGTTTCGTCCTTTCCACAAG |
exon3-sgRNA-F2 | atgCGTCTCaACCGTTGGACAATATACTACCTGTgttttagagctagaaatagcaag |
exon3-sgRNA-R2 | atgCGTCTCgAAACGCGTTCATAACTCTACATGTCGGTGTTTCGTCCTTTCCACAAG |
4.2.2. EB Assay
4.2.3. Cell Proliferation
4.2.4. Cell Apoptosis Assay
4.2.5. Alkaline Phosphatase Staining
4.2.6. Real-Time PCR and RT-PCR
4.2.7. RNA-Seq and Differential Gene Expression Analysis
4.2.8. Immunofluorescence Staining
4.2.9. Gene Ontology, KEGG and Functional Domain Cluster Analysis
4.2.10. Coimmunoprecipitation (Co-IP)
4.2.11. Western Blotting
4.2.12. Transcription Elongation Assay
4.2.13. Native RNA Immunoprecipitation (RIP)
4.2.14. Nuclear Extracts (NEs) Preparation
5. Statistical Analysis
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Evans, M.J.; Kaufman, M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292, 154–156. [Google Scholar] [CrossRef] [PubMed]
- Martin, G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 1981, 78, 7634–7638. [Google Scholar] [CrossRef] [PubMed]
- Boyer, L.A.; Lee, T.I.; Cole, M.F.; Johnstone, S.E.; Levine, S.S.; Zucker, J.P.; Guenther, M.G.; Kumar, R.M.; Murray, H.L.; Jenner, R.G.; et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122, 947–956. [Google Scholar] [CrossRef] [PubMed]
- Nichols, J.; Smith, A. Naive and primed pluripotent states. Cell Stem Cell 2009, 4, 487–492. [Google Scholar] [CrossRef] [PubMed]
- Pan, Q.; Shai, O.; Lee, L.J.; Frey, B.J.; Blencowe, B.J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 2008, 40, 1413–1415. [Google Scholar] [CrossRef]
- Will, C.L.; Lührmann, R. Spliceosome structure and function. Cold Spring Harb. Perspect. Biol. 2011, 3, a003707. [Google Scholar] [CrossRef]
- Chen, W.; Moore, M.J. Spliceosomes. Curr. Biol. CB 2015, 25, R181–R183. [Google Scholar] [CrossRef]
- Aich, M.; Ansari, A.H.; Ding, L.; Iesmantavicius, V.; Paul, D.; Choudhary, C.; Maiti, S.; Buchholz, F.; Chakraborty, D. TOBF1 modulates mouse embryonic stem cell fate through regulating alternative splicing of pluripotency genes. Cell Rep. 2023, 42, 113177. [Google Scholar] [CrossRef]
- Malla, S.; Bhattarai, D.P.; Groza, P.; Melguizo-Sanchis, D.; Atanasoai, I.; Martinez-Gamero, C.; Román, Á.C.; Zhu, D.; Lee, D.; Kutter, C.; et al. ZFP207 sustains pluripotency by coordinating OCT4 stability, alternative splicing and RNA export. EMBO Rep. 2022, 23, e53191. [Google Scholar] [CrossRef]
- Rogalska, M.E.; Vivori, C.; Valcárcel, J. Regulation of pre-mRNA splicing: Roles in physiology and disease, and therapeutic prospects. Nat. Rev. Genet. 2023, 24, 251–269. [Google Scholar] [CrossRef]
- Ule, J.; Blencowe, B.J. Alternative Splicing Regulatory Networks: Functions, Mechanisms, and Evolution. Mol. Cell 2019, 76, 329–345. [Google Scholar] [CrossRef] [PubMed]
- Vermeulen, M.; Eberl, H.C.; Matarese, F.; Marks, H.; Denissov, S.; Butter, F.; Lee, K.K.; Olsen, J.V.; Hyman, A.A.; Stunnenberg, H.G.; et al. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers. Cell 2010, 142, 967–980. [Google Scholar] [CrossRef] [PubMed]
- Yu, S.; Li, J.; Ji, G.; Ng, Z.L.; Siew, J.; Lo, W.N.; Ye, Y.; Chew, Y.Y.; Long, Y.C.; Zhang, W.; et al. Npac Is A Co-factor of Histone H3K36me3 and Regulates Transcriptional Elongation in Mouse Embryonic Stem Cells. Genom. Proteom. Bioinform. 2022, 20, 110–128. [Google Scholar] [CrossRef] [PubMed]
- Tellier, M.; Maudlin, I.; Murphy, S. Transcription and splicing: A two-way street. Wiley Interdiscip. Rev. RNA 2020, 11, e1593. [Google Scholar] [CrossRef]
- Luco, R.F.; Allo, M.; Schor, I.E.; Kornblihtt, A.R.; Misteli, T. Epigenetics in alternative pre-mRNA splicing. Cell 2011, 144, 16–26. [Google Scholar] [CrossRef]
- Sims, R.J.; Millhouse, S.; Chen, C.F.; Lewis, B.A.; Erdjument-Bromage, H.; Tempst, P.; Manley, J.L.; Reinberg, D. Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol. Cell 2007, 28, 665–676. [Google Scholar] [CrossRef]
- Guo, R.; Zheng, L.; Park, J.W.; Lv, R.; Chen, H.; Jiao, F.; Xu, W.; Mu, S.; Wen, H.; Qiu, J.; et al. BS69/ZMYND11 reads and connects histone H3.3 lysine 36 trimethylation-decorated chromatin to regulated pre-mRNA processing. Mol. Cell 2014, 56, 298–310. [Google Scholar] [CrossRef]
- Li, T.; Kon, N.; Jiang, L.; Tan, M.; Ludwig, T.; Zhao, Y.; Baer, R.; Gu, W. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 2012, 149, 1269–1283. [Google Scholar] [CrossRef]
- Aubrey, B.J.; Kelly, G.L.; Janic, A.; Herold, M.J.; Strasser, A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 2018, 25, 104–113. [Google Scholar] [CrossRef]
- Chodosh, L.A.; Fire, A.; Samuels, M.; Sharp, P.A. 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J. Biol. Chem. 1989, 264, 2250–2257. [Google Scholar] [CrossRef]
- Tourasse, N.J.; Millet, J.R.M.; Dupuy, D. Quantitative RNA-seq meta-analysis of alternative exon usage in C. elegans. Genome Res. 2017, 27, 2120–2128. [Google Scholar] [CrossRef] [PubMed]
- Shen, S.; Park, J.W.; Lu, Z.-X.; Lin, L.; Henry, M.D.; Wu, Y.N.; Zhou, Q.; Xing, Y. rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc. Natl. Acad. Sci. USA 2014, 111, E5593–E5601. [Google Scholar] [CrossRef] [PubMed]
- Sun, C. The SF3b complex: Splicing and beyond. Cell. Mol. Life Sci. CMLS 2020, 77, 3583–3595. [Google Scholar] [CrossRef] [PubMed]
- Li, D.; Yu, W.; Lai, M. Towards understandings of serine/arginine-rich splicing factors. Acta Pharm. Sin. B 2023, 13, 3181–3207. [Google Scholar] [CrossRef]
- Cho, S.; Hoang, A.; Sinha, R.; Zhong, X.-Y.; Fu, X.-D.; Krainer, A.R.; Ghosh, G. Interaction between the RNA binding domains of Ser-Arg splicing factor 1 and U1-70K snRNP protein determines early spliceosome assembly. Proc. Natl. Acad. Sci. USA 2011, 108, 8233–8238. [Google Scholar] [CrossRef]
- Nichols, J.; Zevnik, B.; Anastassiadis, K.; Niwa, H.; Klewe-Nebenius, D.; Chambers, I.; Schöler, H.; Smith, A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998, 95, 379–391. [Google Scholar] [CrossRef]
- Avilion, A.A.; Nicolis, S.K.; Pevny, L.H.; Perez, L.; Vivian, N.; Lovell-Badge, R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 2003, 17, 126–140. [Google Scholar] [CrossRef]
- Chambers, I.; Colby, D.; Robertson, M.; Nichols, J.; Lee, S.; Tweedie, S.; Smith, A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113, 643–655. [Google Scholar] [CrossRef]
- Mitsui, K.; Tokuzawa, Y.; Itoh, H.; Segawa, K.; Murakami, M.; Takahashi, K.; Maruyama, M.; Maeda, M.; Yamanaka, S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113, 631–642. [Google Scholar] [CrossRef]
- Loh, Y.-H.; Wu, Q.; Chew, J.-L.; Vega, V.B.; Zhang, W.; Chen, X.; Bourque, G.; George, J.; Leong, B.; Liu, J.; et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 2006, 38, 431–440. [Google Scholar] [CrossRef]
- Olariu, V.; Lövkvist, C.; Sneppen, K. Nanog, Oct4 and Tet1 interplay in establishing pluripotency. Sci. Rep. 2016, 6, 25438. [Google Scholar] [CrossRef] [PubMed]
- Neri, F.; Incarnato, D.; Krepelova, A.; Dettori, D.; Rapelli, S.; Maldotti, M.; Parlato, C.; Anselmi, F.; Galvagni, F.; Oliviero, S. TET1 is controlled by pluripotency-associated factors in ESCs and downmodulated by PRC2 in differentiated cells and tissues. Nucleic Acids Res. 2015, 43, 6814–6826. [Google Scholar] [CrossRef] [PubMed]
- Tilgner, H.; Knowles, D.G.; Johnson, R.; Davis, C.A.; Chakrabortty, S.; Djebali, S.; Curado, J.; Snyder, M.; Gingeras, T.R.; Guigó, R. Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co-transcriptional in the human genome but inefficient for lncRNAs. Genome Res. 2012, 22, 1616–1625. [Google Scholar] [CrossRef] [PubMed]
- Wallace, E.W.J.; Beggs, J.D. Extremely fast and incredibly close: Cotranscriptional splicing in budding yeast. RNA 2017, 23, 601–610. [Google Scholar] [CrossRef]
- Nikom, D.; Zheng, S. Alternative splicing in neurodegenerative disease and the promise of RNA therapies. Nat. Rev. Neurosci. 2023, 24, 457–473. [Google Scholar] [CrossRef]
- Busch, A.; Hertel, K.J. Evolution of SR protein and hnRNP splicing regulatory factors. Wiley Interdiscip. Rev. RNA 2012, 3, 1–12. [Google Scholar] [CrossRef]
- Graveley, B.R.; Maniatis, T. Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing. Mol. Cell 1998, 1, 765–771. [Google Scholar] [CrossRef]
- Fairbrother, W.G.; Yeh, R.-F.; Sharp, P.A.; Burge, C.B. Predictive identification of exonic splicing enhancers in human genes. Science 2002, 297, 1007–1013. [Google Scholar] [CrossRef]
- Änkö, M.-L. Regulation of gene expression programmes by serine-arginine rich splicing factors. Semin. Cell Dev. Biol. 2014, 32, 11–21. [Google Scholar] [CrossRef]
- Fu, X.D.; Maniatis, T. The 35-kDa mammalian splicing factor SC35 mediates specific interactions between U1 and U2 small nuclear ribonucleoprotein particles at the 3′ splice site. Proc. Natl. Acad. Sci. USA 1992, 89, 1725–1729. [Google Scholar] [CrossRef]
- Kohtz, J.D.; Jamison, S.F.; Will, C.L.; Zuo, P.; Lührmann, R.; Garcia-Blanco, M.A.; Manley, J.L. Protein-protein interactions and 5′-splice-site recognition in mammalian mRNA precursors. Nature 1994, 368, 119–124. [Google Scholar] [CrossRef] [PubMed]
- Anczuków, O.; Rosenberg, A.Z.; Akerman, M.; Das, S.; Zhan, L.; Karni, R.; Muthuswamy, S.K.; Krainer, A.R. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat. Struct. Mol. Biol. 2012, 19, 220–228. [Google Scholar] [CrossRef]
- Errichelli, L.; Dini Modigliani, S.; Laneve, P.; Colantoni, A.; Legnini, I.; Capauto, D.; Rosa, A.; De Santis, R.; Scarfò, R.; Peruzzi, G.; et al. FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat. Commun. 2017, 8, 14741. [Google Scholar] [CrossRef] [PubMed]
- Yu, Y.; Reed, R. FUS functions in coupling transcription to splicing by mediating an interaction between RNAP II and U1 snRNP. Proc. Natl. Acad. Sci. USA 2015, 112, 8608–8613. [Google Scholar] [CrossRef] [PubMed]
- Kotzer-Nevo, H.; de Lima Alves, F.; Rappsilber, J.; Sperling, J.; Sperling, R. Supraspliceosomes at defined functional states portray the pre-assembled nature of the pre-mRNA processing machine in the cell nucleus. Int. J. Mol. Sci. 2014, 15, 11637–11664. [Google Scholar] [CrossRef]
- Das, S.; Krainer, A.R. Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer. Mol. Cancer Res. MCR 2014, 12, 1195–1204. [Google Scholar] [CrossRef]
- Pradeepa, M.M.; Sutherland, H.G.; Ule, J.; Grimes, G.R.; Bickmore, W.A. Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing. PLoS Genet. 2012, 8, e1002717. [Google Scholar] [CrossRef]
- Salomonis, N.; Schlieve, C.R.; Pereira, L.; Wahlquist, C.; Colas, A.; Zambon, A.C.; Vranizan, K.; Spindler, M.J.; Pico, A.R.; Cline, M.S.; et al. Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation. Proc. Natl. Acad. Sci. USA 2010, 107, 10514–10519. [Google Scholar] [CrossRef]
- Miao, H.; Wu, F.; Li, Y.; Qin, C.; Zhao, Y.; Xie, M.; Dai, H.; Yao, H.; Cai, H.; Wang, Q.; et al. MALAT1 modulates alternative splicing by cooperating with the splicing factors PTBP1 and PSF. Sci. Adv. 2022, 8, eabq7289. [Google Scholar] [CrossRef]
- Gagliardi, M.; Matarazzo, M.R. RIP: RNA Immunoprecipitation. Methods Mol. Biol. 2016, 1480, 73–86. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Qian, Y.; Ye, Y.; Zhang, W.; Wu, Q. Npac Regulates Pre-mRNA Splicing in Mouse Embryonic Stem Cells. Int. J. Mol. Sci. 2024, 25, 10396. https://doi.org/10.3390/ijms251910396
Qian Y, Ye Y, Zhang W, Wu Q. Npac Regulates Pre-mRNA Splicing in Mouse Embryonic Stem Cells. International Journal of Molecular Sciences. 2024; 25(19):10396. https://doi.org/10.3390/ijms251910396
Chicago/Turabian StyleQian, Yiwei, Ying Ye, Wensheng Zhang, and Qiang Wu. 2024. "Npac Regulates Pre-mRNA Splicing in Mouse Embryonic Stem Cells" International Journal of Molecular Sciences 25, no. 19: 10396. https://doi.org/10.3390/ijms251910396